Stryker Corp (SYK)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$353.00

Buy

$358.61

arrow-up$1.12 (+0.32%)

Prices updated at 12 Dec 2025, 23:56 EST

Prices minimum 15 mins delay

Prices in USD

Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Kevin A. Lobo

CEO

Mr. Kevin A. Lobo

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

53,000

Head office

1941 Stryker Way

Portage

United States

49002

+1 269 385-2600

jason.beach@stryker.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Spencer S. Stiles Group President, Orthopaedics and Spine	0.75m
Mr. Preston W. Wells Vice President and Chief Financial Officer	-
Mr. Dylan Crotty President, Instruments	-
Ms. Ronda E. Stryker Independent Director	0.13m
Ms. Sherilyn S. McCoy Lead Independent Director	0.17m
Ms. Mary K. Brainerd Independent Director	0.14m
Mr. Andrew K. Silvernail Independent Director	0.15m
Mr. Kevin A. Lobo Chairman of the Board, Chief Executive Officer and President	1.44m
Dr. Giovanni Caforio, M.D. Independent Director	0.13m
Mr. William E. Berry, Jr Vice President, Corporate Controller and Chief Accounting Officer	-
Mr. Rajeev Suri Independent Director	0.13m
Ms. Lisa M. Skeete Tatum Independent Director	0.13m
Ms. Yin C. Becker Vice President and Chief Corporate Affairs Officer	-
Ms. M. Kathryn Fink Vice President and Chief Human Resources Officer	-
Mr. Viju S. Menon Group President, Global Quality and Operations	0.65m
Mr. Robert S Fletcher Vice President and Chief Legal Officer	-
Ms. Rachel M. Ruggeri Independent Director	0.08m
Mr. J. Andrew Pierce Group President, MedSurg and Neurotechnology	0.75m
Mr. Emmanuel P. Maceda Independent Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	33,500,571
BlackRock Inc	26,728,719
JPMorgan Chase & Co	23,880,302
Greenleaf Trust	16,643,488
State Street Corp	14,942,900

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
27 Dec 2024	-
27 Dec 2024	-
27 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
23 Dec 2024	-
17 Dec 2024	-
18 Nov 2024	-
18 Nov 2024	-
18 Nov 2024	-
15 Nov 2024	-
14 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.